Cargando…

FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis

Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis, apoptosis, and redox signaling. In addition to being a boon for the normal functioning of a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalathil, Dhanya, John, Samu, Nair, Asha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927600/
https://www.ncbi.nlm.nih.gov/pubmed/33680951
http://dx.doi.org/10.3389/fonc.2020.626836
_version_ 1783659707249983488
author Kalathil, Dhanya
John, Samu
Nair, Asha S.
author_facet Kalathil, Dhanya
John, Samu
Nair, Asha S.
author_sort Kalathil, Dhanya
collection PubMed
description Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis, apoptosis, and redox signaling. In addition to being a boon for the normal functioning of a cell, FOXM1 turns out to be a bane by manifesting in several disease scenarios including cancer. It has been given an oncogenic status based on several evidences indicating its role in tumor development and progression. FOXM1 is highly expressed in several cancers and has also been implicated in poor prognosis. A comprehensive understanding of various aspects of this molecule has revealed its role in angiogenesis, invasion, migration, self- renewal and drug resistance. In this review, we attempt to understand various mechanisms underlying FOXM1 gene and protein regulation in cancer including the different signaling pathways, post-transcriptional and post-translational modifications. Identifying crucial molecules associated with these processes can aid in the development of potential pharmacological approaches to curb FOXM1 mediated tumorigenesis.
format Online
Article
Text
id pubmed-7927600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79276002021-03-04 FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis Kalathil, Dhanya John, Samu Nair, Asha S. Front Oncol Oncology Forkhead box transcription factor, FOXM1 is implicated in several cellular processes such as proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis, apoptosis, and redox signaling. In addition to being a boon for the normal functioning of a cell, FOXM1 turns out to be a bane by manifesting in several disease scenarios including cancer. It has been given an oncogenic status based on several evidences indicating its role in tumor development and progression. FOXM1 is highly expressed in several cancers and has also been implicated in poor prognosis. A comprehensive understanding of various aspects of this molecule has revealed its role in angiogenesis, invasion, migration, self- renewal and drug resistance. In this review, we attempt to understand various mechanisms underlying FOXM1 gene and protein regulation in cancer including the different signaling pathways, post-transcriptional and post-translational modifications. Identifying crucial molecules associated with these processes can aid in the development of potential pharmacological approaches to curb FOXM1 mediated tumorigenesis. Frontiers Media S.A. 2021-02-15 /pmc/articles/PMC7927600/ /pubmed/33680951 http://dx.doi.org/10.3389/fonc.2020.626836 Text en Copyright © 2021 Kalathil, John and Nair http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kalathil, Dhanya
John, Samu
Nair, Asha S.
FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
title FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
title_full FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
title_fullStr FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
title_full_unstemmed FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
title_short FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
title_sort foxm1 and cancer: faulty cellular signaling derails homeostasis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927600/
https://www.ncbi.nlm.nih.gov/pubmed/33680951
http://dx.doi.org/10.3389/fonc.2020.626836
work_keys_str_mv AT kalathildhanya foxm1andcancerfaultycellularsignalingderailshomeostasis
AT johnsamu foxm1andcancerfaultycellularsignalingderailshomeostasis
AT nairashas foxm1andcancerfaultycellularsignalingderailshomeostasis